UK regulator says data from Pfizer, AstraZeneca vaccine rollout confirms safety By Reuters

LONDON (Reuters) – Britain’s medicine regulator on Friday said that data from the first weeks of the rollout of Pfizer (NYSE:PFE) and AstraZeneca (NASDAQ:AZN) COVID-19 vaccines confirmed their good safety profiles, saying both shots met strict regulatory standards.

“The data we have collected provides further reassurance that the COVID-19 vaccines are safe and continue to meet the rigorous regulatory standards required for all vaccines,” June Raine, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), said in a statement.

“We remain confident that the benefits of these vaccines outweigh any risks.”